NNC 55-0396 is a nonhydrolyzable analog of Mibefradil dihydrochloride (sc-204083) which functions as a selective T-type calcium channel protein inhibitor. Studies indicate that NNC 55-0396 displays similar potency on T-type Ca2+ currents in HEK 293/α1G as Mibefradil. NNC 55-0396 can be an essential tool in preventing human ovarian cancer cell proliferation as a result of its ability to inhibit the function of T-type Ca2+ channels. It is believed that NNC 55-0396 may function by dissolving in or passing through the plasma membrane of cells.
1. Huang, L., et al. 2004. J. Pharmacol. Exp.Ther. 309: 193-199.<
See how others have used NNC 55-0396 (CAS 357400-13-6). Click on the entry to view the PubMed entry .
PMID: # 30755443 Visa, A. et al. 2019. Cancer Res.
PMID: # 24316474 2014. Neuroscience. 259: 126-41.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.